Biological Sample Collection Kits Market by Product Type, Sample Type, Application, End-User

Description

List of Tables

[193 Pages Report] The Biological Sample Collection Kits Market size was estimated at USD 8.60 billion in 2023 and expected to reach USD 9.31 billion in 2024, at a CAGR 8.57% to reach USD 15.29 billion by 2030.

Biological sample collection kits are specialized packages designed to facilitate the collection, storage, and transportation of various biological samples for research, diagnostic, and therapeutic purposes. These kits contain all necessary components, such as swabs, vials, tubes, and preservative fluids, ensuring the integrity and viability of the samples from the point of collection to analysis. The emergence of infectious diseases and the ongoing need for medical research amplify the requirement for efficient biological sample collection methods. Growing innovations in genomics, proteomics, and metabolomics necessitate robust sample collection solutions to support complex analyses. The availability of stringent regulations regarding sample collection, storage, and transportation encourages the adoption of standardized collection kits that comply with international standards. The emerging trend toward point-of-care and at-home testing solutions has increased the need for user-friendly and reliable sample collection kits. High development and maintenance of high-quality collection kits are impacting their adoption, especially in resource-limited settings, hampering the growth of the market. Ongoing improvements in sample preservation techniques and materials that enhance the performance and utility of collection kits are expected to create opportunities for market growth.

KEY MARKET STATISTICS
Base Year [2023]	USD 8.60 billion
Estimated Year [2024]	USD 9.31 billion
Forecast Year [2030]	USD 15.29 billion
CAGR (%)	8.57%

Product Type: Growing usage of blood collection kits for the efficient and safe collection of blood samples

Blood collection kits are integral components in diagnostics, medical research, and therapeutic practices. These kits are designed for the efficient and safe collection, transport, and processing of blood samples. They typically include needles, vacutainers or syringes, antiseptics, labels, and sometimes anticoagulants to preserve the integrity of the blood sample. Their usage spans a wide range of applications from basic research to clinical diagnostics, ensuring accurate results in blood analysis for disease detection, blood typing, and biochemical analysis. Swabs play a crucial role in the collection of samples from different mucosal surfaces of the body, such as the nose, throat, and urogenital tract, for diagnostic testing. They are specially designed to collect and transfer biological samples with maximum efficacy to a testing platform without compromising the sample quality. Swabs are commonly used in microbiology for detecting viral infections, bacterial colonization, or for DNA testing. The types of swabs include nasal swabs, oral swabs, and others, each tailored for specific sample collection needs. Viral transport media is a crucial product for the safe transport of viruses, chlamydia, mycoplasma, and ureaplasma samples from the collection site to the testing laboratory. VTM is designed to maintain the viability of the viral particles by providing a controlled environment that prevents specimen deterioration due to temperature changes or contamination. This is particularly important in infectious disease diagnostics and research, where the integrity of the sample directly affects the accuracy of the test results. VTMs are formulated according to the specific requirements of different types of tests and include buffers, protein sources, antibiotics to inhibit bacterial and fungal growth, and cryoprotectants for sample preservation.

End-User: High potential of blood collection kits across diagnostic centers for collecting various types of biological samples

Blood banks are a crucial end-user in the global biological sample collection kits market. They rely on these kits for the safe and efficient collection, storage, and processing of blood and blood components. These kits help ensure the integrity and purity of the samples, which is critical for transfusions and other medical treatments. The demand for blood banks is driven by the need for standardized procedures in blood collection and storage, as well as increasing awareness about blood donation and its importance. Diagnostic centers constitute a significant segment of the end-user market for biological sample collection kits. These centers utilize these kits for collecting various types of biological samples, such as blood, urine, saliva, and others, for the purpose of diagnosis and disease monitoring. The accuracy and reliability of diagnostic results greatly depend on the quality of sample collection, making high-quality collection kits essential. The growing demand for early and accurate disease diagnosis drives the need for these kits in diagnostic centers. Hospitals represent a major end-user group for biological sample collection kits. In this setting, the kits are used across various departments for numerous applications, including clinical testing, research, and treatment monitoring. The versatility and reliability of these kits are vital for hospitals to provide timely and accurate diagnosis and treatment to patients. The increasing emphasis on preventive care and personalized medicine in hospitals further bolsters the demand for advanced sample collection solutions.

Regional Insights

The Americas represents a significant market for biological sample collection kits due to the robust healthcare infrastructure, high healthcare spending, and the presence of a large number of key players in the region. North America is the significant contributor, driven by advanced research facilities, rising investments in diagnostics and personalized medicine, and growing awareness regarding disease diagnosis. Additionally, the increasing prevalence of chronic diseases and the strong focus on healthcare innovation in countries including Canada and Brazil further augment the demand for these kits. Regulatory support for quality healthcare services and an established network for early disease detection and monitoring also play a crucial role in market growth. The Asia-Pacific region is witnessing rapid growth in the biological sample collection kits market, attributed to its expanding healthcare infrastructure, rising healthcare expenditure, and growing awareness regarding the importance of early diagnosis. Countries including China and India, with their large population bases and increasing prevalence of infectious and non-infectious diseases, present significant opportunities for market expansion. The area is also seeing a rise in governmental and private investment in healthcare research and development, adding to the demand for collection kits. The EMEA region's market for biological sample collection kits is diverse due to the high demand for advanced healthcare facilities, a well-established pharmaceutical and biotechnology research sector, and supportive governmental healthcare policies across countries such as Germany, the UK, and France. The Middle East and Africa are expected to grow, driven by the gradual improvement in healthcare infrastructure, increasing awareness about health among the population, and rising investments in healthcare by governments, especially in the Gulf Cooperation Council (GCC) countries.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Biological Sample Collection Kits Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biological Sample Collection Kits Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Biological Sample Collection Kits Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Avantor, Inc., B. Braun SE, Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., Biosigma S.p.A., Cardinal Health, Inc., Eurofins Scientific SE, Exelint International, Co., F. Hoffmann-La Roche Ltd., F.L. Medical S.r.l., Globe Scientific Inc., Greiner AG, Haemonetics Corporation, ICU Medical, Inc., Medtronic PLC, Merck KGaA, Nipro Medical Corporation, Qiagen N.V., Retractable Technologies, Inc., Siemens Healthineers AG, Terumo Corporation, Thermo Fisher Scientific Inc., and Zymo Research Corporation.

Market Segmentation & Coverage

This research report categorizes the Biological Sample Collection Kits Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product Type
- Blood Collection Kits
- Swabs
- Viral Transport Media

Sample Type
- Blood
- Saliva
- Stool
- Tissue
- Urine

Application
- Diagnostics
- Treatment

End-User
- Blood Banks
- Diagnostic Centers
- Hospitals

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Biological Sample Collection Kits Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biological Sample Collection Kits Market?

3. What are the technology trends and regulatory frameworks in the Biological Sample Collection Kits Market?

4. What is the market share of the leading vendors in the Biological Sample Collection Kits Market?

5. Which modes and strategic moves are suitable for entering the Biological Sample Collection Kits Market?

Product Code: MRR-F97DD5A7DF04

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising emergence of infectious diseases and the ongoing need for medical research
  - 5.1.1.2. Availability of stringent regulations regarding sample collection, storage, and transportation
  - 5.1.1.3. Increasing development of diagnostic centers worldwide
- 5.1.2. Restraints
  - 5.1.2.1. Complexity in the maintenance of high-quality collection kits
- 5.1.3. Opportunities
  - 5.1.3.1. Ongoing technological improvements in biological sample collection kits
  - 5.1.3.2. Emerging trend towards point-of-care and at-home testing solutions
- 5.1.4. Challenges
  - 5.1.4.1. Improper design of kits and inaccuracy of results
5.2. Market Segmentation Analysis
- 5.2.1. Product Type: Growing usage of blood collection kits for the efficient and safe collection of blood samples
- 5.2.2. End-User: High potential of blood collection kits across diagnostic centers for collecting various types of biological samples
5.3. Market Disruption Analysis
5.4. Porter's Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Biological Sample Collection Kits Market, by Product Type

6.1. Introduction
6.2. Blood Collection Kits
6.3. Swabs
6.4. Viral Transport Media

7. Biological Sample Collection Kits Market, by Sample Type

7.1. Introduction
7.2. Blood
7.3. Saliva
7.4. Stool
7.5. Tissue
7.6. Urine

8. Biological Sample Collection Kits Market, by Application

8.1. Introduction
8.2. Diagnostics
8.3. Treatment

9. Biological Sample Collection Kits Market, by End-User

9.1. Introduction
9.2. Blood Banks
9.3. Diagnostic Centers
9.4. Hospitals

10. Americas Biological Sample Collection Kits Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Biological Sample Collection Kits Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Biological Sample Collection Kits Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
- 13.3.1. Takara Bio's First-to-market Large-Scale Single-cell NGS Profiling Technologies Poised to Revolutionize Biomarker Discovery
- 13.3.2. BD Receives FDA 510(k) Clearance for Potentially Transformative Fingertip Blood Collection Device
- 13.3.3. Cue Health's New Suite of At-Home Diagnostic Tests and Expansion of Cue Care Puts You in Control of Your Health
13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

14.1. Key Company Profiles
14.2. Key Product Portfolio